Arteris Inc

Arteris insider sales reveal tactical trading, not a strategic sell‑off—yet strong fundamentals and IP growth keep investors hopeful for future gains.

Arteris CEO sells 50,000 shares amid rising stock—insider trades signal portfolio balancing, not a loss of confidence.

Arteris CFO’s mixed buy‑sell moves reveal a cautious but bullish stance on the company’s NoC IP future – a key insider signal for investors.

Arteris insider selling continues—Viana Family Trust’s 10‑b‑1 plan, exec tranches, and social‑media buzz show a disciplined liquidity strategy amid strong earnings.

Arteris insider Viana Antonio J sells 20,000 shares—plan‑driven, routine, not a red flag—showing disciplined gains amid bullish market and strong semiconductor growth.

Arteris COO Moll Laurent R sells 1,993 shares amid a near‑52‑week high, hinting at a planned liquidity move rather than panic—investors should watch price volatility after the new partnership launch.

Arteris insider sales surge: CEO and Bayview Legacy off‑load $2.7M of shares amid bullish momentum, hinting at portfolio rebalancing and potential price impact.

Arteris insider trading shows modest shifts: Claudia Munce’s recent buy signals confidence amid tax‑related sales, boosting investors’ view of the company’s growth potential.

Arteris CEO’s 10(b)(5)(1) sales show disciplined liquidity, not panic – still strong growth, 52‑week highs, and a diversified semiconductor pipeline.

Arteris insider selling: Bayview Legacy’s recent March sales reveal CEO K. Charles Janac’s liquidity strategy amid weak earnings, prompting investors to monitor future trades for market shifts.